Earnings call transcript: Everspin posts record Q3 2026 revenue, stock falls after hours

Everspin reported record Q3 2026 revenue of $20.6 million, up 47% year over year, and non-GAAP EPS of $0.12 versus a forecast loss of $0.03; revenue also exceeded its $19.5 million-$20.5 million guidance range. Q4 guidance calls for revenue of $21.5 million-$22.5 million and non-GAAP EPS of $0.13-$0.18, while management expects substantial litigation costs and sequential product-margin improvement after price increases. Despite the beat, shares fell 9.9% after hours to $13.20; Q3 GAAP operating expenses rose to $18.5 million, including $6 million in litigation costs.

Analysis

The key issue is earnings quality, not whether the quarter beat: service/licensing revenue helped the mix, but its repeatability and the conversion of design wins into recurring product shipments remain unproven. Product-cost inflation also means the announced price increases must translate into sequential product-margin improvement before the growth story supports a higher multiple. Meanwhile, non-GAAP profitability excludes litigation costs that remain substantial near term, so the headline EPS surprise overstates the cash-earnings signal investors should underwrite.

The after-hours selloff reads as a credibility test rather than a clean rejection of demand. Q4 guidance points to continued sequential growth, but does not yet establish that NOR replacement demand is material or durable; management says it is included in guidance and has not quantified it. That is the near-term catalyst to track. Over 6–18 months, CXL, LPDDR persistent memory and newer aerospace products offer meaningful optionality, but standards work, qualification and customer sampling leave a long gap between demonstrations and revenue. The Teledyne Technologies partnership could widen Everspin’s route into defense customers, but no disclosed economics support a material near-term read-through to TDY.

The contrarian risk is that investors may be treating a small, volatile company’s legal and product-cost burden as temporary while underweighting execution risk and the quality of non-product revenue. Conversely, extrapolating the after-hours decline into a structural demand break is premature absent weaker shipments or guidance. Litigation resolution, price realization, and shipment conversion—not demos or design-win anecdotes—should determine the next leg.

Key Decisions for Investors

• Do not chase the after-hours move in either direction at the open. Keep Everspin on a catalyst watchlist; consider a long only after the next report confirms sequential product-margin improvement and revenue conversion, with a thesis stop if guidance is cut or product sales weaken sequentially.
• For an existing Everspin long, size to small-cap/liquidity and litigation-event risk rather than to the non-GAAP EPS beat. Reassess after the ALJ milestone and verify actual litigation cash expense, any resolution terms, and whether the export-control provision changes.
• Track Q4 product gross margin, price realization, and the product-versus-licensing/services revenue mix. Failure of product margins to improve despite pricing, or growth concentrated in non-product revenue, would falsify the constructive operating thesis.
• Treat NOR-flash substitution as an alert, not an earnings estimate: verify customer/distributor demand, units, and repeat orders before assigning durable revenue. Constrained NOR supply may support incumbent suppliers, but the article does not identify which suppliers have available capacity or pricing leverage.
• No actionable TDY or IFX trade from this disclosure alone. TDY’s partnership economics are undisclosed; any read-through to Infineon Technologies AG (IFX) from NOR-market changes is indirect and should be revisited only with evidence on capacity allocation, pricing, or customer substitution.